Bringing a broader range of services through an ecosystem of expert CRO partners
As experts in VHHs we respect the expertise of other contract research organizations with complementary specialties, partnering to bring our customers rapid access and seamless project management to build their perfect antibody discovery campaign.
Axxam
High-throughput screening, assay development, target validation
Isogenica’s antibody discovery platforms are combined with Axxam’s screening and assay capabilities. This includes target development with recombinant proteins and cells. The collaboration speeds up the progression from antibody discovery to lead identification. It enhances assay development and brings complementary expertise, reducing fragmentation and inefficiency. This leads to earlier and high throughput functional assessment.
Cube Biotech
Making purified versions of challenging targets like membrane proteins
The collaboration between Cube Biotech and Isogenica enhances Isogenica’s ability to meet target requirements for challenging discoveries. This partnership ensures a steady supply of high-quality proteins for discovery campaigns. It also streamlines downstream workflows, leading to better timelines and reduced risks for therapeutic development programs.
Partnerships at Isogenica
Despite the confidentiality of our clients, Isogenica consistently receives high satisfaction ratings, with 100% of VHH discovery customers rating between 8 and 10/10 on how likely they would be to recommend our organization to a friend or colleague. Isogenica’s partnerships with global biopharmaceutical companies have resulted in a deep pipeline including three clinical-stage assets (Phase I and Phase II) and dozens of partnered pre-clinical and discovery programs. Contact us to find out how to revolutionise your research and development with VHH antibody technologies.